BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32556920)

  • 1. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
    El Adoui M; Drisis S; Benjelloun M
    Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Explainable Deep CNN Design for Classifying Breast Tumor Response Over Neoadjuvant Chemotherapy.
    Adoui ME; Drisis S; Benjelloun M
    Curr Med Imaging; 2022; 19(5):526-533. PubMed ID: 36529908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
    Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
    Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
    Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
    Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.
    Ma M; Gan L; Jiang Y; Qin N; Li C; Zhang Y; Wang X
    Comput Math Methods Med; 2021; 2021():2140465. PubMed ID: 34422088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer.
    Zhang B; Yu Y; Mao Y; Wang H; Lv M; Su X; Wang Y; Li Z; Zhang Z; Bian T; Wang Q
    Acad Radiol; 2024 Mar; 31(3):800-811. PubMed ID: 37914627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset.
    Ha R; Chin C; Karcich J; Liu MZ; Chang P; Mutasa S; Pascual Van Sant E; Wynn RT; Connolly E; Jambawalikar S
    J Digit Imaging; 2019 Oct; 32(5):693-701. PubMed ID: 30361936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning of quantitative ultrasound multi-parametric images at pre-treatment to predict breast cancer response to chemotherapy.
    Taleghamar H; Jalalifar SA; Czarnota GJ; Sadeghi-Naini A
    Sci Rep; 2022 Feb; 12(1):2244. PubMed ID: 35145158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
    Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
    Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
    Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
    Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
    Jun W; Cong W; Xianxin X; Daqing J
    Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm.
    Ha R; Chang P; Karcich J; Mutasa S; Van Sant EP; Connolly E; Chin C; Taback B; Liu MZ; Jambawalikar S
    Ann Surg Oncol; 2018 Oct; 25(10):3037-3043. PubMed ID: 29978368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.
    Aghaei F; Tan M; Hollingsworth AB; Zheng B
    J Magn Reson Imaging; 2016 Nov; 44(5):1099-1106. PubMed ID: 27080203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
    Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
    Joo S; Ko ES; Kwon S; Jeon E; Jung H; Kim JY; Chung MJ; Im YH
    Sci Rep; 2021 Sep; 11(1):18800. PubMed ID: 34552163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.